MARKET

CERS

CERS

Cerus Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.470
+0.130
+3.00%
After Hours: 4.470 0 0.00% 16:40 11/15 EST
OPEN
4.370
PREV CLOSE
4.340
HIGH
4.530
LOW
4.330
VOLUME
1.39M
TURNOVER
--
52 WEEK HIGH
6.88
52 WEEK LOW
3.950
MARKET CAP
634.78M
P/E (TTM)
-8.7527
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CERS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CERS News

  • Benzinga's Top Upgrades, Downgrades For November 13, 2019
  • Benzinga.2d ago
  • Cerus Corporation to Present at the Stifel 2019 Healthcare Conference
  • Business Wire.2d ago
  • BofAML likes Alnylam in premarket analyst action
  • Seeking Alpha - Article.2d ago
  • BTIG Research Upgrades Cerus to Buy
  • Benzinga.2d ago

More

Industry

Medical Equipment, Supplies & Distribution
+1.46%
Healthcare Equipment & Supplies
+1.93%

Hot Stocks

Name
Price
%Change

About CERS

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company's INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The Company's INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, including human immunodeficiency virus (HIV), West Nile, Severe acute respiratory syndrome (SARS), hepatitis B and C; bacteria and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products. The Company's INTERCEPT Blood System is for use with blood components, including plasma, platelets, and red blood cells.
More

Webull offers Cerus Corporation (CERS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.